nivolumab
bms
['nivo', 'rcc,(-irccs),(-srcc),(-urcc)']
prosper: periop nivo versus obs in patients with rcc undergoing nephrectomy nivo + surg vs surg: rfs: hr 0.97, 95% ci 0.74 1.28 os: hr 1.48, 95% ci 0.89 2.48 gr 3/4 aes: 20% vs 6% deaths from rcc: 4% vs 4% #esmo22 
Uro Onc @GACancerCenter | Res PD & Ronald W. Lewis MD Chair of Uro Educ @mcg_urology | Digital Media Ed @EUplatinum | #mentalhealth research | @urotoday